Synthesis, Characterization and Primary Antimicrobial Activity Evaluation of 3-Phenyl-6-methyl-4(3H)-quinazolinone-2-yl-mercaptoacetic Acid Arylidenehydrazides
3-Phenyl-6-methyl-4(3H)-quinazolinone-2-yl-mercaptoacetic acid hydrazide (3) was reacted with substituted aldehydes in absolute ethanol to obtain a new series, 3-phenyl-6-methyl-4(3H)-quinazolinone- 2-yl-mercaptoacetic acid arylidenehydrazides (4a-q). The structures of 4a-q were elucidated by elemental analyses and from spectrometric (UV, IR, 1H-NMR, 13C-NMR and EIMS) data. Then 4a-q were evaluated for antibacterial, antifungal and antitubercular activities. No significant activity was observed against the selected microorganisms.
Synthesis, Characterization and Primary Antimicrobial Activity Evaluation of 3-Phenyl-6-methyl-4(3H)-quinazolinone-2-yl-mercaptoacetic Acid Arylidenehydrazides
3-Phenyl-6-methyl-4(3H)-quinazolinone-2-yl-mercaptoacetic acid hydrazide (3) was reacted with substituted aldehydes in absolute ethanol to obtain a new series, 3-phenyl-6-methyl-4(3H)-quinazolinone- 2-yl-mercaptoacetic acid arylidenehydrazides (4a-q). The structures of 4a-q were elucidated by elemental analyses and from spectrometric (UV, IR, 1H-NMR, 13C-NMR and EIMS) data. Then 4a-q were evaluated for antibacterial, antifungal and antitubercular activities. No significant activity was observed against the selected microorganisms.
___
- A.E-N. Ahmed, M.A. Abd-Alla and M.F. El-Zohry, J. Chem. Tech. Biotech. 43, 63-70 (1988).
- J. Bartroli, E. Turmo, M. Alguero, E. Boncompte, M.L. Vericat, L. Conte, J. Ramis, M. Merlos, J. Garcia- Rafanell and J. Forn, J. Med. Chem. 41, 1869-1882 (1998).
- A.A. Shalaby, A.M.A. El-Khamry, S.A. Shiba, A.A.A.E.A Ahmed and A.A. Hanafi, Arch. Pharm. (Wein- heim) 333, 365-372 (2000).
- P. Kumar, K.N. Dhawan, S. Vrat, K.P. Bhargava and K. Kishore, Arch. Pharm. (Weinheim) 316, 759-763 (1983).
- J.W. Corbett, S.S. Ko, J.D. Rodgers, L.A. Gearhart, N.A. Magnus, L.T. Bacheler, S. Diamond, S. Jeffrey, R.M. Klabe, B.C. Cordova, S. Garber, K. Logue, G.L. Trainor, P.S. Anderson and S.K. Erickson-Viitanen, J. Med. Chem. 43, 2019-2030 (2000).
- M.J. Hour, L.J. Huang, S.C. Kuo, Y. Xia, K. Bastow, Y. Nakanishi, E. Hamel and K.H. Lee, J. Med. Chem. , 4479-4487 (2000).
- E. Hamel, C.M. Lin, J. Plowman, H.K. Wang, K.H. Lee and K.D. Paull, Biochem. Pharmacol. 51, 53-59 (1996).
- C.O. Usifoh and G.K.E. Scriba, Arch. Pharm. (Weinheim) 333, 261-266 (2000).
- M.M. Said and M.M.M. Hussein, Bull. Fac. Pharm. (Cairo Univ.) 32, 341-347 (1994). Chem. Abstr. 1996, : 300939.
- N. Karalı, E. ˙Ilhan, A. G¨ursoy and M. Kiraz, Farmaco 53, 346-349 (1998).
- A. G¨ursoy, N. Karalı, S. B¨uy¨uktimkin, S¸. Demirayak, A.C. Ekinci and H. ¨Ozer, Farmaco 51, 437-442 (1996).
- S.G. Abdel-Hamide, M.M. Ghorab and O.A. Badary, Egypt. J. Biotechnol. 1, 36-45 (1997).
- T.N. Ghosh, J. Indian Chem. Soc. 7, 981-983 (1930).
- A. G¨ursoy and N. Karalı, Eur. J. Med. Chem. 38, 633-643 (2003).
- N.S. Habib and M.A. Khalil, J. Pharm. Sci. 73, 982-985 (1984).
- K. Spirkova, S. Stankovsky, A. Mrvova and L. Cipak, Chem. Pap-Chem. Zvesti. 53, 272-275 (1999).
- A. G¨ursoy and N. ˙Ilhan, Farmaco 50, 559-563 (1995).
- S. Spasov, I. Atanasova and M. Haimova, Magn. Reson. Chem. 23, 795-799 (1985).
- R. Lakhan and B.J. Rai, J. Chem. Eng. Data 32, 384-386 (1987).
- F.J. Martinez-Martinez, A. Ariza-Castolo, V. Ramos-Nava, N. Barba-Behrens and R. Contreras, Magn. Reson. Chem. 31, 832-835 (1993).
- A. G¨ursoy and N. Karalı, Farmaco 50, 857-866 (1995).
- M. Himottu, K. Pihlaja, G. Stajer and P. Vainiotalo, Rapid Commun. Mass Spectrom. 7, 374-377 (1993).
- A.L. Barry and C. Thornsberry, “Manual of Clinical Microbiology”, E.H. Lennette, A. Balows, W.J. Hausler and H.J. Shadomy, pp. 978, ASM, Washington DC, 1985.
- C.B. Inderleid, “Antibiotics in Laboratory Medicine”, V. Lorian, pp. 134-197, 3rded. Williams and Wilkins, Baltimore, 1991.
- N. Karalı, N. Terzio˘glu and A. G¨ursoy, Arzneim. Forsch./ Drug Res. 48, 758-763 (1998).